Status:
COMPLETED
Determine the Effect of Multiple Doses of AZD7325, CYP Study
Lead Sponsor:
AstraZeneca
Conditions:
Healthy Volunteer
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
To determine the effects of repeated doses of AZD7325 on the pharmacokinetic profile of a CYP3A4 substrate (midazolam and its 1' hydroxy metabolite) and a CYP1A2 substrate (caffeine and its paraxanthi...
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- Clinically relevant abnormalities in physical examinations, vital signs, clinical chemistry, hematology or urinalysis as judged by the investigator and/or sponsor.
- Enrollment in another concurrent investigational study or intake of an investigational drug within 3 months or intake of an investigational drug within a period of 5 half lives of that drug prior to the screening visit
Exclusion
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00790114
Start Date
July 1 2008
End Date
September 1 2008
Last Update
November 13 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.